News | February 3, 2020
![](https://devyser.com/hubfs/Imagery/IM-2022-sample_prep.jpg)
Related Articles
View all![](https://devyser.com/hubfs/20240523_SoMe_Devyser_tender_thalassemia_italy_.psd%20%286%29.png)
![](https://devyser.com/hubfs/20240523_SoMe_Devyser_tender_thalassemia_italy_.psd%20%285%29.png)
Devyser wins tender in Sweden for Thalassemia NGS testing worth up to 8.4 million SEK
Read More
![](https://devyser.com/hubfs/PR%20announcement%20AZF.png)
Devyser announces expanded commercial agreement with Thermo Fisher Scientific for post-transplant monitoring NGS products
Read More
![](https://devyser.com/hubfs/AZF%20%20Ext%20v2%20launch.png)
Devyser launches updated Y-Chromosomal microdeletion test
Read More